Assenagon Asset Management S.A. Cara Therapeutics, Inc. Transaction History

Assenagon Asset Management S.A.

$47.8 Billion
Q3 2024

A detailed history of Assenagon Asset Management S.A. transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 13,653 shares of CARA stock, worth $70,586. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,653

Previous 14,353 4.88%

Holding current value

$70,586

Previous $3,000 33.33%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$0.26 - $0.38 $182 - $266	-700 Reduced 4.88%	13,653 $4,000
Q2 2024 Jul 18, 2024	SELL	$0.24 - $0.92 $38,154 - $146,259	-158,978 Reduced 91.72%	14,353 $3,000
Q1 2024 Apr 24, 2024	BUY	$0.52 - $1.05 $2,856 - $5,767	5,493 Added 3.27%	173,331 $157,000
Q4 2023 Jan 17, 2024	BUY	$0.6 - $1.65 $61,338 - $168,679	102,230 Added 155.82%	167,838 $124,000
Q3 2023 Nov 06, 2023	BUY	$1.67 - $3.33 $109,565 - $218,474	65,608 New	65,608 $110,000
Q4 2022 Jan 12, 2023	BUY	$8.88 - $12.77 $611,334 - $879,137	68,844 Added 210.53%	101,544 $1.09 Million
Q3 2022 Oct 27, 2022	SELL	$8.24 - $12.56 $121,111 - $184,606	-14,698 Reduced 31.01%	32,700 $306,000
Q2 2022 Jul 27, 2022	BUY	$7.45 - $13.84 $353,115 - $655,988	47,398 New	47,398 $433,000
Q3 2021 Oct 19, 2021	SELL	$11.55 - $16.06 $8.46 Million - $11.8 Million	-732,041 Closed	0 $0
Q2 2021 Jul 15, 2021	BUY	$12.38 - $29.19 $8.27 Million - $19.5 Million	668,159 Added 1045.93%	732,041 $10.4 Million
Q1 2021 Apr 26, 2021	BUY	$15.07 - $21.71 $429,841 - $619,234	28,523 Added 80.67%	63,882 $1.39 Million
Q4 2020 Feb 01, 2021	SELL	$12.72 - $16.16 $1.64 Million - $2.08 Million	-128,941 Reduced 78.48%	35,359 $534,000
Q3 2020 Oct 07, 2020	BUY	$12.34 - $17.92 $2.03 Million - $2.94 Million	164,300 New	164,300 $2.09 Million
Q1 2020 Apr 17, 2020	SELL	$9.12 - $17.78 $567,209 - $1.11 Million	-62,194 Closed	0 $0
Q4 2019 Jan 17, 2020	BUY	$16.11 - $25.98 $1 Million - $1.62 Million	62,194 New	62,194 $1 Million

Others Institutions Holding CARA

# of Institutions

Shares Held

12.8M

Call Options Held

Put Options Held

View Full List

About Cara Therapeutics, Inc.

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $278M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

More about CARA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Account

Assenagon Asset Management S.A. Cara Therapeutics, Inc. Transaction History